Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded ATP synthase 6 pseudogene 18 (MTATP6P18) is a pseudogene, meaning it is a genomic sequence similar to the functional MT-ATP6 gene but lacks the ability to produce a functional protein due to disabling mutations. The functional MT-ATP6 gene encodes a subunit of mitochondrial ATP synthase involved in oxidative phosphorylation and cellular energy production[1][5][6]. MTATP6P18, however, does not encode any functional protein, participates in recognized biological pathways, or serve as a known receptor, enzyme, transporter, or therapeutic target. There are no established disease associations, drug interactions, diagnostic roles, or therapeutic safety concerns related to MTATP6P18. If you intended the functional MT-ATP6 gene (not the pseudogene), please clarify. The MT-ATP6 gene is critical in cell energy metabolism and a documented disease gene[1][5], but "MTATP6P18" refers specifically to a non-coding pseudogene derivative.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded ATP synthase 6 pseudogene 18 (MTATP6P18).